Founded in 2010, Spot On Sciences is a life science company offering proprietary medical devices for biospecimen sampling. Our innovative and patented HemaSpot™ devices transform the collection, storage, and transport of blood by advancing the dried blood spot (DBS) technology. We enable more precise and individualized healthcare by providing the tools for practitioners and patients to do in-the-field biospecimen collection, and specimen testing. Our Company is positioned to be the market leader and standard of care for all biospecimen collection, storage, and transport.
Chief Executive Officer
Chief finance & operations Officer
Dr. Dana Welle
A History of
Inspired to provide better healthcare to her elderly, home-bound, rural mother, Jeanette Hill created the HemaSpot device in order to take remote, clinical quality blood samples. Addressing the long standing Hematocrit problem associated with DBS, HemaSpot’s innovative paper quality dramatically reduces this concern, and opens the door to new opportunities and applications. Watch interview here.
- Bill & Melinda Gates Foundation
- National Institutes of Health
2011 – 2015
2011: Cartier Women’s Initiative Award – North America
2013: SXSW Interactive Accelerator – Finalist
2013: RISE Global Pitch Competition – Winner
2014: 1776 Challenge Cup, US Winner – Health Category
2014: Kauffman Foundation Champion of ‘Get in the Ring’ – The North American Startup Clash; International Finalist
2015: White House Demo Day – Honoree
2018 – 2022
Spot On Sciences was acquired by Tribeca Companies in October 2018. Post-acquisition, Spot On Sciences is expanding its portfolio of products and transitioning the devices from research tools into global commercial products.